Title:
Anticancer pyrid pyrazine through prevention of FGFR kinase
Document Type and Number:
Japanese Patent JP6169583
Kind Code:
B2
Abstract:
The invention relates to new pyridopyrazine derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Inventors:
Valerio, Berdini
Gordon, Saxty
Patrick, René, Anguibo
Olivier, Alexis, Georges, Keroll
Birginie, Sophie, Poncelet
Bruno, Lou
Leven, Meer Paul
Gordon, Saxty
Patrick, René, Anguibo
Olivier, Alexis, Georges, Keroll
Birginie, Sophie, Poncelet
Bruno, Lou
Leven, Meer Paul
Application Number:
JP2014537730A
Publication Date:
July 26, 2017
Filing Date:
October 26, 2012
Export Citation:
Assignee:
ASTEX THERAPEUTICS LIMITED
International Classes:
C07D471/04; A61K31/4985; A61K31/519; A61K31/5377; A61P1/04; A61P1/16; A61P11/00; A61P13/08; A61P13/10; A61P15/00; A61P35/00; A61P43/00; C07D519/00
Domestic Patent References:
| JP2010526794A | ||||
| JP2001518496A | ||||
| JP2007500195A | ||||
| JP2006528223A | ||||
| JP2009515854A |
Attorney, Agent or Firm:
Yukitaka Nakamura
Hirohito Katsunuma
Noritaka Yokota
Yuko Matsuyama
Hirohito Katsunuma
Noritaka Yokota
Yuko Matsuyama
Previous Patent: The liquid crystal display panel in fringe field switching mode
Next Patent: MOTOR CONTROLLER FITTED WITH POSITIONER
Next Patent: MOTOR CONTROLLER FITTED WITH POSITIONER